Angelalign Technology to Challenge Court Decision on Premolar Extraction Solution with No Customer Impact

Angelalign's Legal Stand on Premolar Extraction Solution

In a recent announcement, Angelalign Technology Inc. (6699.HK), a prominent player in the orthodontic aligner market, declared its intent to appeal a court ruling made by the Jinan Intermediate People's Court in China. This ruling, made on August 10, instructed the company's Chinese subsidiaries to halt the use of its masterForce biomechanics simulation system, along with the ATreat digital diagnosis and design system, specifically for generating its A7 and A7 Speed premolar extraction solutions. However, the company has emphasized that this initial decision does not currently affect its clients or patients.

The Basis for the Appeal

Angelalign firmly believes that the A7 Premolar Extraction Solution does not violate any existing patents. The company has a history of successfully defending its patents in various jurisdictions worldwide and is committed to promoting fair competition in the aligner and scanner markets. According to Fox Hu, the CEO of Angel, "The court's decision is limited to China. Even in China, there is no immediate impact on our customers. We are optimistic about our capacity to support orthodontists globally and believe in our chances of prevailing in the appeal."

This optimistic view is bolstered by previous court successes; notably, on May 12, 2026, the Local Division Düsseldorf of the Unified Patent Court in Germany ruled against the request for a preliminary injunction demanding Angel to stop using the A7 Premolar Extraction Solution. This decision remains final, as the Plaintiff did not appeal it.

Consistent Success in Patent Disputes

In June 2026, another significant ruling came from the Zhengzhou Intermediate People's Court of China, which dismissed claims from the Plaintiff against Angel relating to two separate patent infringement disputes. The Plaintiff has since appealed those judgments. Angelalign has engaged actively with issues of intellectual property, demonstrating respect for innovation throughout its operational history, which spans over 20 years and includes developing sophisticated orthodontic technologies.

Angelalign's products—recognized for treating complex orthodontic cases—have garnered the attention of top orthodontists globally. Some of its competitors even aspire to incorporate concepts such as angelButton™ and the A6 Mandibular Advancement System into their offerings, highlighting Angelalign's innovative influence on the market.

Financial Health and Market Confidence

With a market valuation exceeding $2 billion, Angelalign boasts robust profitability and a healthy balance sheet. These factors reinforce the company as a reliable long-term partner for orthodontists aiming for outstanding clinical results. The legal case in question forms part of a broader patent infringement lawsuit initiated by Align Technology Inc. (ALGN). Angelalign maintains that it does not infringe upon the plaintiff's patents, a claim the company stands firm on.

Future Outlook

As Angelalign embarks on this legal journey, it continues to uphold its commitment to innovation and customer care. Established in 2003, the company has delivered over 2 million smiles globally and operates in more than 60 countries and regions, having expanded its footprint into the North American market in recent years. The establishment of a new 52,000 sq. ft. manufacturing facility in the U.S. underlines Angelalign's commitment to sustaining growth and service quality.

For users seeking more information, Angelalign has published legal proceedings related to this case on their official website. As this story develops, stakeholders are keenly interested in how the appeal will unfold and its potential implications on the industry.